Genetic Medicine Advances: Dravet Gene Editing, Prenatal Hemophilia Therapy, and Valproate Risk Test
Gene editing repaired a Dravet syndrome mutation in mice, a prenatal hemophilia A therapy showed maternal safety in sheep, and researchers advanced toward a genetic test for valproic acid use in pregnancy.